Triad Business Report High Point Company Ponders Next Move on Alzheimer's DrugNovember 3, 2012A High Point pharmaceutical company is at a critical juncture: whether it will continue the clinical trial process on it's Alzheimer's drug alone, abandon the process or look for a new financial partner.
|
Triad Business Report archives
|
|
| Su |
M |
T |
W |
Th |
F |
Sa | | | 1 | 2 | 3 | 4 | 5 | 6 | | 7 | 8 | 9 | 10 | 11 | 12 | 13 | | 14 | 15 | 16 | 17 | 18 | 19 | 20 | | 21 | 22 | 23 | 24 | 25 | 26 | 27 | | 28 | 29 | 30 | | | | |
|
